Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS, Delhi
New Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here Thursday. ...
Read moreNew Delhi: The phase-three human clinical trial of indigenously developed anti-coronavirus vaccine candidate Covaxin began at the AIIMS here Thursday. ...
Read moreNew Delhi: India’s COVID-19 caseload surpassed the 90-lakh mark Friday with 45,882 new cases the Union Health Ministry said. The ...
Read moreHyderabad: Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech Monday ...
Read moreNew Delhi: The Serum Institute of India (SII) and the Indian Council of Medical Research (ICMR) Thursday announced the completion ...
Read moreNew Delhi: The Bacille Calmette-Guerin or BCG vaccine, originally made against tuberculosis, may help in the management of Covid-19, especially ...
Read moreNew Delhi: India saw 48,648 new coronavirus infections being reported in a day taking the COVID-19 caseload to 80,88,851. However, the ...
Read moreBhubaneswar: The third phase of the human of the indigenous COVID-19 vaccine COVAXIN, will commence at a private hospital here ...
Read moreNew Delhi: COVID-19 recoveries in India have crossed 69 lakh the Union Health Ministry said Friday. Meanwhile the number of ...
Read moreBhubaneswar: Months after convalescent plasma (CP) therapy for serious Covid patients began in the state, serious doubts over its efficacy ...
Read moreNew Delhi: The number of new coronavirus infections reported daily in India dropped below 60,000 for the second time this ...
Read more